189 related articles for article (PubMed ID: 26295952)
1. Nanocarriers in Improved Heparin Delivery: Recent Updates.
Kurmi BD; Tekchandani P; Paliwal R; Paliwal SR
Curr Pharm Des; 2015; 21(30):4509-18. PubMed ID: 26295952
[TBL] [Abstract][Full Text] [Related]
2. Heparin-coated colloidal mesoporous silica nanoparticles efficiently bind to antithrombin as an anticoagulant drug-delivery system.
Argyo C; Cauda V; Engelke H; Rädler J; Bein G; Bein T
Chemistry; 2012 Jan; 18(2):428-32. PubMed ID: 22161774
[No Abstract] [Full Text] [Related]
3. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
Shahbazi MA; Hamidi M; Mohammadi-Samani S
J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
[TBL] [Abstract][Full Text] [Related]
4. Heparin-Tailored Biopolymeric Nanocarriers in Site-Specific Delivery: A Systematic Review.
Garg A; Sharma R; Pandey V; Patel V; Yadav AK
Crit Rev Ther Drug Carrier Syst; 2017; 34(1):1-33. PubMed ID: 28322139
[TBL] [Abstract][Full Text] [Related]
5. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
6. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam.
Dasgupta S; Ray S; Dey S; Pal P; Mazumder B
Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909
[TBL] [Abstract][Full Text] [Related]
7. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in anticoagulant drug delivery.
Park J; Byun Y
Expert Opin Drug Deliv; 2016; 13(3):421-34. PubMed ID: 26612251
[TBL] [Abstract][Full Text] [Related]
9. Trends in the development of oral anticoagulants.
Ralay-Ranaivo B; Borgel D; Couvreur P; Gref R
Ther Deliv; 2015; 6(6):685-703. PubMed ID: 26149785
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
12. Current developments for the oral delivery of heparin.
Schlüter A; Lamprecht A
Curr Pharm Biotechnol; 2014; 15(7):640-9. PubMed ID: 25219865
[TBL] [Abstract][Full Text] [Related]
13. Host-guest chemistry of dendrimer-drug complexes. 5. Insights into the design of formulations for noninvasive delivery of heparin revealed by isothermal titration calorimetry and NMR studies.
Feng X; Cheng Y; Yang K; Zhang J; Wu Q; Xu T
J Phys Chem B; 2010 Sep; 114(34):11017-26. PubMed ID: 20695473
[TBL] [Abstract][Full Text] [Related]
14. Advanced nanocarriers based on heparin and its derivatives for cancer management.
Yang X; Du H; Liu J; Zhai G
Biomacromolecules; 2015 Feb; 16(2):423-36. PubMed ID: 25517794
[TBL] [Abstract][Full Text] [Related]
15. The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.
Motlekar NA; Youan BB
J Control Release; 2006 Jun; 113(2):91-101. PubMed ID: 16777255
[TBL] [Abstract][Full Text] [Related]
16. Heparin based polyurethanes: A state-of-the-art review.
Zia F; Zia KM; Zuber M; Tabasum S; Rehman S
Int J Biol Macromol; 2016 Mar; 84():101-11. PubMed ID: 26666430
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in search of oral heparin therapeutics.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Med Res Rev; 2012 Mar; 32(2):388-409. PubMed ID: 21287569
[TBL] [Abstract][Full Text] [Related]
19. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview.
Thakur S; Riyaz B; Patil A; Kaur A; Kapoor B; Mishra V
Biomed Pharmacother; 2018 Oct; 106():1011-1023. PubMed ID: 30119166
[TBL] [Abstract][Full Text] [Related]
20. Advanced Drug Delivery Systems for Transdermal Delivery of Non-Steroidal Anti-Inflammatory Drugs: A Review.
Kumar L; Verma S; Singh M; Chalotra T; Utreja P
Curr Drug Deliv; 2018; 15(8):1087-1099. PubMed ID: 29875000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
